Argent Biopharma (AU:RGT) has released an update.
Argent BioPharma Limited has requested a trading halt pending a forthcoming market announcement, concerning an application to be delisted. The halt will remain in effect until either the announcement is made or market opening on Thursday, 15 August 2024. This strategic move has prompted speculation among investors regarding the company’s future plans.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
